Investor mix
5 investors on record; lead investors include Sofinnova Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Bank & private debt | 1 | 20% |
| Other / undisclosed | 2 | 40% |
Developer of gene therapies for neurodegenerative lysosomal storage disorders
5 investors on record; lead investors include Sofinnova Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Bank & private debt | 1 | 20% |
| Other / undisclosed | 2 | 40% |